// App-Quantinova.ai

TCT-607 : Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel/Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results From the SEEDS Study

Researchers

Presenter

  • Bo Xu

Principal Investigators

  • Yuejin Yang

  • Yaling Han

  • Bao Li

  • Qiang Liu

  • Guoying Zhu

  • Junyu Cui

  • Lang Li

  • Shuzheng Lu

Medical Centers

  • Wuhan Asia Heart Hospital,China

  • Shenzhen Sun Yat-Sen Cardiovascular Hospital, Shenzhen, China

  • Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China

  • Shanxi Provincial Cardiovascular Institute, Taiyuan, China

  • Nanjing Military General Hospital, Nanjing, China

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

  • Affilaited Anzhen Hospital of Capital Medical University, Beijing, China

  • Shenyang Northern Hospital, Shenyang City, China, Shenyang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multi-vessel disease

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved